Osteopenia Terminated Phase 2 Trials for Estradiol (DB00783)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01928082The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone MassTreatment